TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Inro Biomedtek AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
436
|
482
|
398 |
| Financial expenses |
0
|
1,236
|
7,802 |
| Earnings before taxes |
302
|
-568
|
-7,375 |
| EBITDA |
342
|
384
|
315 |
| Total assets |
640
|
13,550
|
14,619 |
| Current assets |
553
|
13,408
|
14,422 |
| Current liabilities |
52
|
943
|
1,309 |
| Equity capital |
588
|
12,607
|
13,310 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
91.9%
|
93.0%
|
91.0% |
| Turnover per employee |
436
|
482
|
398 |
| Profit as a percentage of turnover |
69.3%
|
-117.8%
|
-1853.0% |
| Return on assets (ROA) |
47.2%
|
4.9%
|
2.9% |
| Current ratio |
1063.5%
|
1421.8%
|
1101.8% |
| Return on equity (ROE) |
51.4%
|
-4.5%
|
-55.4% |
| Change turnover |
-46
|
84
|
30 |
| Change turnover % |
-10%
|
21%
|
8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.